Experts urge cultural shift and standards to unlock real-world evidence potential in medtech

At The MedTech Conference in Boston, experts highlighted the need for a cultural shift to build trust between regulators and medtech firms when using real-world evidence (RWE) for device marketing.

They argued that without mutual confidence, RWE data may be viewed skeptically, limiting its impact on approvals and reimbursement decisions.

The panel also stressed that establishing clear standards for generating and evaluating RWE is essential to broaden its adoption across the industry.